122 related articles for article (PubMed ID: 6097722)
1. [Studies on hepatic gluconeogenesis in chronic liver diseases; with special references to the effects of L-alanine administration].
Nishimura A
Nihon Shokakibyo Gakkai Zasshi; 1984 Nov; 81(11):2754-66. PubMed ID: 6097722
[No Abstract] [Full Text] [Related]
2. Localization of synaptophysin immunoreactivity in the human liver.
Kanda N; Fukuda Y; Imoto M; Koyama Y; Nakano I; Urano F
Scand J Gastroenterol; 1994 Mar; 29(3):275-9. PubMed ID: 8209189
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.
Pazirandeh S; Khettry U; Gordon FD; Resnick RH; Murray JE; Sheth SG
Dig Dis Sci; 2007 Jan; 52(1):220-7. PubMed ID: 17160481
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase and glutathione in the gastric mucosa of patients with chronic liver disease.
Kikkawa S; Kadohara M; Kawasaki H
Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):289-309. PubMed ID: 1335597
[TBL] [Abstract][Full Text] [Related]
5. S-phase cells in diseased human liver determined by an in vitro BrdU-anti-BrdU method.
Shimizu A; Tarao K; Takemiya S; Harada M; Inoue T; Ono T
Hepatology; 1988; 8(6):1535-9. PubMed ID: 2847968
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
Park BC; Huh MH; Seo JH
J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
[TBL] [Abstract][Full Text] [Related]
7. Tissue remodelling in liver diseases.
Giannelli G; Quaranta V; Antonaci S
Histol Histopathol; 2003 Oct; 18(4):1267-74. PubMed ID: 12973693
[TBL] [Abstract][Full Text] [Related]
8. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
9. [Determination of zinc content in blood, liver tissue, urine and hair of patients with chronic liver diseases and its clinical significance].
Dang ZD
Zhonghua Nei Ke Za Zhi; 1983 Dec; 22(12):758-60. PubMed ID: 6675940
[No Abstract] [Full Text] [Related]
10. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
11. [The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma].
Xie YM; Li X; Yan LN; Wei B; Wang CH; Tang CW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):710-6. PubMed ID: 26619541
[TBL] [Abstract][Full Text] [Related]
12. Proteomics in the study of liver pathology.
Parent R; Beretta L
J Hepatol; 2005 Jul; 43(1):177-83. PubMed ID: 15894398
[No Abstract] [Full Text] [Related]
13. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of hepatic tissue zinc contents in hepatocellular carcinoma and chronic liver diseases].
Kameda Y
Nihon Shokakibyo Gakkai Zasshi; 1983 Dec; 80(12):2556-63. PubMed ID: 6325778
[No Abstract] [Full Text] [Related]
15. Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue.
Kaita KD; Pettigrew N; Minuk GY
Liver; 1997 Feb; 17(1):13-6. PubMed ID: 9062874
[TBL] [Abstract][Full Text] [Related]
16. Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma.
Matsui S; Takahashi T; Oyanagi Y; Takahashi S; Boku S; Takahashi K; Furukawa K; Arai F; Asakura H
J Hepatol; 1997 Nov; 27(5):843-53. PubMed ID: 9382972
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
Harada K; Shiota G; Kawasaki H
Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
[TBL] [Abstract][Full Text] [Related]
18. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis.
Fan ZR; Yang DH; Cui J; Qin HR; Huang CC
World J Gastroenterol; 2001 Apr; 7(2):285-8. PubMed ID: 11819776
[No Abstract] [Full Text] [Related]
20. Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases.
Chen GG; Lai PB; Chak EC; Xu H; Lee KM; Lau WY
Cancer Lett; 2001 Oct; 172(1):75-82. PubMed ID: 11595132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
